Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials-Reference-Cited by-同舟云学术

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials

Published:2015-05 Issue:5 Volume:3 Page:388-396
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Durheim Michael T,Collard Harold R,Roberts Rhonda S,Brown Kevin K,Flaherty Kevin R,King Talmadge E,Palmer Scott M,Raghu Ganesh,Snyder Laurie D,Anstrom Kevin J,Martinez Fernando J

Funder

US National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference26 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis—evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

2. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

3. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N Engl J Med,2014

4. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials;Collard;Respir Res,2013

5. Strategies for treating idiopathic pulmonary fibrosis;du Bois;Nat Rev Drug Discov,2010

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The future of clinical trials in idiopathic pulmonary fibrosis;Current Opinion in Pulmonary Medicine;2024-07-04

2. Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in mice;Scientific Reports;2024-06-14

3. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency;American Journal of Respiratory and Critical Care Medicine;2024-03-15

4. An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis;ERJ Open Research;2024-01

5. Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis;Frontiers in Pharmacology;2023-11-30